Postpartum HIV Care: Addressing a Critical Gap | Elona Toska

The period following childbirth, known as the postpartum period, represents a frequently overlooked but critical juncture in HIV care. Recent research, highlighted by Elona Toska, MSc, DPhil, underscores the significant gaps in support and treatment continuity for individuals living with HIV during these months. This isn’t simply a matter of extending existing care; the postpartum period presents unique physiological and logistical challenges that demand a tailored approach to ensure sustained viral suppression and maternal and infant health.

The Postpartum Period: A Time of Increased Vulnerability

The postpartum period, typically defined as the first six to twelve weeks after delivery, is a time of profound physical and emotional change. For women living with HIV, these changes can exacerbate existing vulnerabilities and introduce new risks. Hormonal shifts, sleep deprivation, and the demands of newborn care can all contribute to challenges in adhering to antiretroviral therapy (ART). ART is a medication regimen used to control HIV, preventing it from progressing to AIDS and reducing the risk of transmission. Disruptions in ART adherence can lead to viral rebound – a return to detectable levels of the virus in the blood – which not only jeopardizes the mother’s health but also increases the risk of transmitting HIV to the infant, even with prior ART during pregnancy.

The issue is particularly acute for adolescent mothers. A study in South Africa, as reported by Aidsmap, found that adolescent mothers with HIV experienced poorer HIV outcomes compared to their non-mother counterparts. This suggests that the challenges of motherhood are compounded for younger women, potentially due to factors like limited social support, lower socioeconomic status, and reduced access to healthcare.

Why Current Systems Fall Short

The reasons for these gaps in care are multifaceted. Traditional HIV care models often focus on the pregnant woman during pregnancy, with a strong emphasis on preventing mother-to-child transmission (PMTCT). However, this focus can wane after delivery, as the immediate risk of transmission decreases. The postpartum period is often treated as a transition phase, with women expected to seamlessly integrate into routine HIV care. However, this transition is rarely smooth.

Several logistical barriers contribute to the problem. Postpartum appointments are often scheduled around infant care, making it challenging for mothers to attend. Transportation challenges, childcare responsibilities, and competing demands on time can all hinder access to care. Healthcare providers may not be adequately trained to address the specific needs of postpartum women living with HIV, including mental health concerns, breastfeeding support (with appropriate ART), and family planning counseling.

The Importance of Integrated Care

Addressing this critical gap requires a shift towards more integrated and comprehensive HIV care models. This means extending the intensive support provided during pregnancy into the postpartum period, with a focus on proactive outreach, individualized care plans, and streamlined access to services.

As highlighted in reporting from the European AIDS Treatment Group, research presented at CROI 2026 emphasizes the need to recognize the postpartum period as a distinct and vulnerable phase in HIV care. This includes ensuring that women have access to ongoing ART support, mental health services, and social support networks. Integrating HIV care with maternal and child health services can also improve access and coordination of care.

Understanding Viral Suppression and Transmission Risk

Maintaining viral suppression is paramount. When a person living with HIV consistently takes ART as prescribed, the amount of virus in their blood is reduced to undetectable levels. This not only protects their own health but also effectively eliminates the risk of sexual transmission – a concept known as “Undetectable = Untransmittable” or U=U. However, achieving and maintaining viral suppression requires ongoing adherence to ART and regular monitoring. Any interruption in treatment can lead to viral rebound and an increased risk of transmission.

While the risk of mother-to-child transmission is significantly reduced with ART during pregnancy and delivery, We see not entirely eliminated. Postpartum viral rebound can still pose a risk to the infant, particularly during breastfeeding. Continued ART and viral monitoring are crucial for women who choose to breastfeed.

What Comes Next: Surveillance, Guidance, and Research

The recognition of the postpartum period as a critical gap in HIV care is prompting a reevaluation of existing guidelines and a call for increased research. Public health agencies are likely to focus on strengthening surveillance systems to better track HIV outcomes among postpartum women. This includes monitoring ART adherence, viral load, and rates of mother-to-child transmission.

Updates to national and international HIV treatment guidelines are also anticipated, with a greater emphasis on postpartum care. These updates may include recommendations for more frequent monitoring, tailored support services, and strategies to address the unique challenges faced by postpartum women living with HIV. Further research is needed to identify effective interventions to improve ART adherence, address mental health concerns, and enhance social support networks for this vulnerable population. The American Journal of Managed Care® (AJMC®) has been actively reporting on these developments, signaling a growing awareness of the issue within the medical community.

addressing this critical gap requires a collaborative effort involving healthcare providers, public health agencies, researchers, and community organizations. By prioritizing the needs of postpartum women living with HIV, You can improve their health outcomes and prevent the transmission of HIV to the next generation.